摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butan-2-yl]isoindole-1,3-dione

中文名称
——
中文别名
——
英文名称
2-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butan-2-yl]isoindole-1,3-dione
英文别名
2-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-2-yl]isoindole-1,3-dione
2-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butan-2-yl]isoindole-1,3-dione化学式
CAS
——
化学式
C23H27N3O3
mdl
——
分子量
393.5
InChiKey
DCMZWBLLDCYRFE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    29
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    53.1
  • 氢给体数:
    0
  • 氢受体数:
    5

文献信息

  • Deuterium-Enriched Alkyl Sulfonamides and Uses Thereof
    申请人:Dhanoa Daljit Singh
    公开号:US20140221395A1
    公开(公告)日:2014-08-07
    The present invention is concerned with deuterium-enriched sulfonamides of formula 1, their pharmaceutically acceptable salts and methods of use thereof for the treatment of anxiety disorders including, General Anxiety Disorder (GAD), Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), Social Phobia (SP), Health Anxiety (Hypochondriasis), depression, major depressive disorders, unipolar depression, bipolar I depression disorder, bipolar II depression disorder, treatment-resistant depression, single episodic and recurrent major depressive disorders, depression in the medically ill, attention deficit hyperactivity disorder (ADHD), attention deficit disorder (ADD), Obsessive-Compulsive Disorder (OCD), Obsessive-Compulsive Personality Disorder (OCPD), Autism Spectrum Disorder (ASD), schizophrenia, psychosis, epilepsy, seizures, hot flashes due to menopause, age-related macular degeneration (AMD), premature ejaculation, male erectile dysfunction, sexual dysfunction, obesity, eating disorders, bulimia nervosa, anorexia nervosa, angina, migraine, pain, nociception, sleep disorders, insomnia, fibromyalgia, alcohol withdrawal, autism, Rett's syndrome, cyclothymic disorder, neural injury, neurodegenerative diseases, Parkinson's disease, Parkinson's disease psychosis, Huntington disease, Alzheimer's disease, frontotemporal dementia, cognitive impairment associated with age-related dementia, Alzheimer's disease, schizophrenia, psychosis, depression, pain or discomfort associated with surgery and pain or discomfort associated with medical illness.
  • US8927553B2
    申请人:——
    公开号:US8927553B2
    公开(公告)日:2015-01-06
查看更多